Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18561875 | 0.79 | KIF11 (0.60) | KIF11DNMT1 | |
| SCHEMBL15031000 | 0.79 | KIF11 (0.60) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL768202 | 0.79 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL6891349 | 0.79 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL768203 | 0.79 | KIF11 (0.85) | KIF11DNMT1 | |
| SCHEMBL11544954 | 0.79 | KIF11 (0.60) | KIF11DNMT1 | |
| SCHEMBL28551163 | 0.78 | KIF11 (0.55) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190178 | 0.77 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190175 | 0.77 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL655694 | 0.77 | KIF11 (0.82) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110117009-A1 | DRUG CONJUGATES WITH POLYGLYCEROLS | FREIE UNIVERSITÄT BERLIN (DE) | 2011-05-19 | — | — | US | disclosed |
| EP-2268315-A1 | DRUG CONJUGATES WITH POLYGLYCEROLS | Freie Universität Berlin (DE) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009121564-A1 | DRUG CONJUGATES WITH POLYGLYCEROLS | FREIE UNIVERSITÄT BERLIN (DE) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117009-A1 | DRUG CONJUGATES WITH POLYGLYCEROLS | DDOST, STT3A, STT3B | KIF11 588/4885DNMT1 4161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.